Five Prime Therapeutics and Bristol-Myers Squibb sign collaboration agreement
- Details
- Category: Bristol-Myers Squibb

Sanofi and UCB partner for breakthrough innovation in immune-mediated diseases
- Details
- Category: Sanofi

GSK increases stake in Indian Pharmaceuticals subsidiary to 75 %
- Details
- Category: GlaxoSmithKline

Pradaxa® (dabigatran etexilate) now approved in more than 100 countries for stroke prevention in atrial fibrillation
- Details
- Category: Boehringer Ingelheim

Bristol-Myers Squibb announces charitable donation of $1 million
- Details
- Category: Bristol-Myers Squibb

Novartis extends leadership in clinical trial data transparency
- Details
- Category: Novartis

Eliquis® (apixaban) reduced the risk of stroke and demonstrated fewer major bleeding events versus Warfarin
- Details
- Category: Pfizer

More Pharma News ...
- Boehringer Ingelheim receives East Bay Innovation Award
- Novartis expands cancer immunotherapy research program with acquisition of CoStim
- Crystal Bioscience and Boehringer Ingelheim announce multiple target antibody discovery collaboration
- Pfizer and Merck to collaborate on innovative anti-cancer combination studies
- Amgen and Merck announce collaboration To evaluate investigational combination treatment for advanced melanoma
- Bristol-Myers Squibb completes previously announced sale of global diabetes business to AstraZeneca
- Roche delivers strong 2013 results